651 related articles for article (PubMed ID: 19141086)
1. Protective effects of melatonin against oxidative stress in Fmr1 knockout mice: a therapeutic research model for the fragile X syndrome.
Romero-Zerbo Y; Decara J; el Bekay R; Sanchez-Salido L; Del Arco-Herrera I; de Fonseca FR; de Diego-Otero Y
J Pineal Res; 2009 Mar; 46(2):224-34. PubMed ID: 19141086
[TBL] [Abstract][Full Text] [Related]
2. Enhanced markers of oxidative stress, altered antioxidants and NADPH-oxidase activation in brains from Fragile X mental retardation 1-deficient mice, a pathological model for Fragile X syndrome.
el Bekay R; Romero-Zerbo Y; Decara J; Sanchez-Salido L; Del Arco-Herrera I; Rodríguez-de Fonseca F; de Diego-Otero Y
Eur J Neurosci; 2007 Dec; 26(11):3169-80. PubMed ID: 18005058
[TBL] [Abstract][Full Text] [Related]
3. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome.
Spencer CM; Alekseyenko O; Serysheva E; Yuva-Paylor LA; Paylor R
Genes Brain Behav; 2005 Oct; 4(7):420-30. PubMed ID: 16176388
[TBL] [Abstract][Full Text] [Related]
4. Fmr1 knockout mice are impaired in a leverpress escape/avoidance task.
Brennan FX; Albeck DS; Paylor R
Genes Brain Behav; 2006 Aug; 5(6):467-71. PubMed ID: 16923151
[TBL] [Abstract][Full Text] [Related]
5. Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium.
Cell; 1994 Jul; 78(1):23-33. PubMed ID: 8033209
[TBL] [Abstract][Full Text] [Related]
6. Alpha-tocopherol protects against oxidative stress in the fragile X knockout mouse: an experimental therapeutic approach for the Fmr1 deficiency.
de Diego-Otero Y; Romero-Zerbo Y; el Bekay R; Decara J; Sanchez L; Rodriguez-de Fonseca F; del Arco-Herrera I
Neuropsychopharmacology; 2009 Mar; 34(4):1011-26. PubMed ID: 18843266
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of Autism-associated genes in the brain of Fragile X mouse model.
Zhang A; Shen CH; Ma SY; Ke Y; El Idrissi A
Biochem Biophys Res Commun; 2009 Feb; 379(4):920-3. PubMed ID: 19138667
[TBL] [Abstract][Full Text] [Related]
8. A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse.
Yan QJ; Asafo-Adjei PK; Arnold HM; Brown RE; Bauchwitz RP
Genes Brain Behav; 2004 Dec; 3(6):337-59. PubMed ID: 15544577
[TBL] [Abstract][Full Text] [Related]
9. Audiogenic seizure susceptibility is reduced in fragile X knockout mice after introduction of FMR1 transgenes.
Musumeci SA; Calabrese G; Bonaccorso CM; D'Antoni S; Brouwer JR; Bakker CE; Elia M; Ferri R; Nelson DL; Oostra BA; Catania MV
Exp Neurol; 2007 Jan; 203(1):233-40. PubMed ID: 17007840
[TBL] [Abstract][Full Text] [Related]
10. Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins.
Spencer CM; Serysheva E; Yuva-Paylor LA; Oostra BA; Nelson DL; Paylor R
Hum Mol Genet; 2006 Jun; 15(12):1984-94. PubMed ID: 16675531
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the performance of individuals with fragile X syndrome and Fmr1 knockout mice on Hebb-Williams mazes.
MacLeod LS; Kogan CS; Collin CA; Berry-Kravis E; Messier C; Gandhi R
Genes Brain Behav; 2010 Feb; 9(1):53-64. PubMed ID: 19796132
[TBL] [Abstract][Full Text] [Related]
12. Altered synaptic plasticity in a mouse model of fragile X mental retardation.
Huber KM; Gallagher SM; Warren ST; Bear MF
Proc Natl Acad Sci U S A; 2002 May; 99(11):7746-50. PubMed ID: 12032354
[TBL] [Abstract][Full Text] [Related]
13. The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo.
Mientjes EJ; Nieuwenhuizen I; Kirkpatrick L; Zu T; Hoogeveen-Westerveld M; Severijnen L; Rifé M; Willemsen R; Nelson DL; Oostra BA
Neurobiol Dis; 2006 Mar; 21(3):549-55. PubMed ID: 16257225
[TBL] [Abstract][Full Text] [Related]
14. Mouse model of fragile X syndrome: behavioral and hormonal response to stressors.
Nielsen DM; Evans JJ; Derber WJ; Johnston KA; Laudenslager ML; Crnic LS; Maclean KN
Behav Neurosci; 2009 Jun; 123(3):677-86. PubMed ID: 19485574
[TBL] [Abstract][Full Text] [Related]
15. Possible involvement of GABAergic mechanism in protective effect of melatonin against sleep deprivation-induced behaviour modification and oxidative damage in mice.
Kumar A; Singh A
Fundam Clin Pharmacol; 2009 Aug; 23(4):439-48. PubMed ID: 19709322
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mouse model for the fragile X syndrome.
Kooy RF; D'Hooge R; Reyniers E; Bakker CE; Nagels G; De Boulle K; Storm K; Clincke G; De Deyn PP; Oostra BA; Willems PJ
Am J Med Genet; 1996 Aug; 64(2):241-5. PubMed ID: 8844056
[TBL] [Abstract][Full Text] [Related]
17. Corticosterone response to acute stress in a mouse model of Fragile X syndrome.
Markham JA; Beckel-Mitchener AC; Estrada CM; Greenough WT
Psychoneuroendocrinology; 2006 Jul; 31(6):781-5. PubMed ID: 16621323
[TBL] [Abstract][Full Text] [Related]
18. Social behavior phenotypes in fragile X syndrome, autism, and the Fmr1 knockout mouse: theoretical comment on McNaughton et al. (2008).
Brodkin ES
Behav Neurosci; 2008 Apr; 122(2):483-9. PubMed ID: 18410188
[TBL] [Abstract][Full Text] [Related]
19. Fragile X syndrome, the Fragile X related proteins, and animal models.
Hoogeveen AT; Willemsen R; Oostra BA
Microsc Res Tech; 2002 May; 57(3):148-55. PubMed ID: 12112450
[TBL] [Abstract][Full Text] [Related]
20. Effects of Fragile X syndrome and an FMR1 knockout mouse model on forebrain neuronal cell biology.
Churchill JD; Beckel-Mitchener A; Weiler IJ; Greenough WT
Microsc Res Tech; 2002 May; 57(3):156-8. PubMed ID: 12112451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
